Clinomics, Inc. engages in the development and commercialization of cancer and disease early diagnosis technology services. Its products and services include COVID-19 test kits, liquid biopsy and precision medicine, health care, and big data. The company was founded on June 21, 2011 and is headquartered in Ulsan, South Korea.